Enasidenib
| Use attributes for filter ! | |
| Trade name | Idhifa |
|---|---|
| ATC code | L01XX59 (WHO) |
| ChemSpider ID | 38772329 |
| ChEBI ID | 145374 |
| PubChem CID | 89683805 |
| Music groups | Ivosidenib |
| Cladribine | |
| Therapy | |
| Gilteritinib | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951169 |
About Enasidenib
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 gene, determined by an FDA-approved IDH2 companion diagnostic test. It is an inhibitor of IDH2.
